SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-17-004914
Filing Date
2017-03-21
Accepted
2017-03-21 17:10:39
Documents
5
Effectiveness Date
2017-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 vktx-s8.htm S-8 112583
2 EX-5.1 vktx-ex51_7.htm EX-5.1 27961
3 EX-23.1 vktx-ex231_6.htm EX-23.1 3114
4 GRAPHIC g2017032116595994246847.jpg GRAPHIC 11200
5 GRAPHIC g2017032117000038446847.jpg GRAPHIC 17892
  Complete submission text file 0001564590-17-004914.txt   185040
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216857 | Film No.: 17704865
SIC: 2834 Pharmaceutical Preparations